Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02064218
NCT02064218
Unknown
Not Applicable

Evaluation of Some Emerging Biomarkers of Cardiovascular Risk Stratification in Hypertensive Patients: a 5-years Follow-up

University of Pavia1 site in 1 countryStarted: November 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHypertension
InterventionsAnti-hypertensive drugs
DrugsAnti-hypertensive drugs

Overview

Phase
Not Applicable
Locations
1
Primary Endpoint
Blood pressure reduction
OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

First of all to evaluate the relationship between non-conventional biomarkers and essential hypertension; then to evaluate the effects of various anti-hypertensive drugs on blood pressure control and non-conventional biomarkers in naive hypertensive patients

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 64 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •essential hypertension
  • •naive to treatment
  • •\< 65 years

Exclusion Criteria

  • •secondary hypertension
  • •previous cardiovascular events

Arms & Interventions

Hypertensive patients

Hypertensive patients naive to hypertensive treatment

Intervention: Anti-hypertensive drugs (Drug)

Outcomes

Primary Outcomes

Blood pressure reduction

Time Frame: 5 years

* Systolic Blood Pressure (SBP) * Diastolic Blood Pressure (DBP)

Secondary Outcomes

  • Cardiovascular and metabolic biomarkers(5 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Giuseppe Derosa

MD, PhD

University of Pavia

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Not Applicable
Evaluation of novel biomarkers in cardiovascular and metabolic diseaseObesity, hypertension, diabetes, dyslipidemia, ishcemic heart disease, heart failure, renal failure
JPRN-UMIN000007095Second Department of Internal Medicine, Sapporo Medical University500
Not yet recruiting
Not Applicable
Applying Novel Biomarkers to Assess Cardiac Risk in Patients Undergoing Major Vascular Surgery: Defining Iron, Oxidative Stress, Inflammation, Matrix Metalloproteinases, Coagulation Factors, Lipidomics, Endothelial Dysfunction and Other Relevant Markers as Novel Risk Predictors
ACTRN12608000437369The Alfred Hospital200
Recruiting
Not Applicable
Novel Biomarkers in Patients With Acute Myocardial InfarctionCardiovascular DiseasesMyocardial InfarctionAcute Coronary SyndromeBiochemical Dysfunction
NCT05791916Aristotle University Of Thessaloniki500
Recruiting
Not Applicable
Prediction Models for Cardiovascular and Neurocognitive Disease Risk in the General PopulationAnesthesia, LocalAnesthesia
NCT05951764Assistance Publique - Hôpitaux de Paris396
Recruiting
Not Applicable
Identification of new biomarkers in cardiac ischemiaI25I25.1Chronic ischaemic heart diseaseAtherosclerotic heart disease
DRKS00030534Klinik für Kardiologie, Angiologie und Pneumologie, Universitätsklinikum Heidelberg200